Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: What is the evidence for its benefit?

✍ Scribed by Joseph M. Geskey; Gary D. Ceneviva; Gretchen L. Brummel; Gavin R. Graff; Maria-Cristina Javier

• Book ID: 116371703
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 711 KB
• Volume: 26
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2004.12.005